Trial intelligence / Profile preview

Gemcitabine vs GOFL Induction in Locally Advanced Pancreatic Cancer

NCT01063192Phase 2Unknown

Sponsor
National Health Research Institutes
Start
Nov 2009
Primary completion
Sep 2013
Modality
DNA Intercalators/Alkylators
01

Overview

A Phase 2 trial of oxaliplatin, fluorouracil in pancreatic cancer (PC), sponsored by National Health Research Institutes. Status: unknown.

02

Drugs

oxaliplatinfluorouracil
03

Conditions

pancreatic cancer (PC)

Beyond the preview

Go deeper on NCT01063192.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01063192.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call